Contattaci contattaci
logo

Gallarate

Manufacturing site

Gallarate is the group plant dedicated to the production of nutraceuticals in solid forms, medical devices for oral use and sports nutrition products. Gallarate is specialized in the design and production of multi-layer tablets and advance coating solutions for healthcare industry. The factory continues to innovate and supply integrated solutions for a wide range of production requirements.

Facility Facts

Distintive technologies

Gallarate facility delivers rapid and flexible solutions for the development and production of different major solid dosage forms. With a focus on innovation and quality, the plant specializes in a wide variety of galenic formulations, expertly tailored to meet the diverse needs of our customers:

  • multi-layer tablets

  • ODT (orally disintegrating tablets)

  • Chewable tablets

Multi-layer tablets

Multi-layer tablet is an innovative technology for the oral administration of advanced formulations, incorporating active ingredients or mixtures of active substances with controlled and sustained release in a single product. Thanks to this technology, the product's action is optimised over time, ensuring a more targeted and effective action in the body. A guarantee in health care, for long-lasting, high-performance results.

Main advantages:

  1. Prevention of incompatibility between active ingredients and excipients, which are kept separate from each other until the time of administration

  2. Administration of the same or different substances, with controlled release and with a direct and diversified action in the target area

  3. The use of separate layers and different colours differentiates the product from other tablets and provides visual evidence of the use of different groups of ingredients (e.g. vitamins and minerals)

Microencapsulation

To date, Biofarma Group is the first CDMO in the Italian nutraceutical field to use this innovative patented German technology, that offers an advanced solution for coating and protecting ingredients. Suitable for powders, capsules and tablets, this technology keeps ingredients active and stabilised, ensuring controlled release at the ideal time.

Main advantages:

  • gastroresistance

  • taste-masking 

  • controlled release

  • better solubility of hydrophobic substances

  • combination of different substances for better bioavailability and absorption

Certified excellence

ISO 13485 (Medical Devices); ISO 9001; GMP CRF TITLE 21, VOL 2, PART 111 (Supplements); PET FOOD SUPPLEMENT AUTHORIZATION (ART 10 OF REG. 183/2005/CE); FOOD SAFETY SYSTEM CERTIFICATION FSSC 22000; KOSHER; HALAL; BIOLOGIC; FDA REGISTRATION

logo
© Biofarma Srl C.F. e P.IVA 02895910301
T. +39 0432 868711 F. +39 0432 868018
Via Castelliere, 2
33036 Mereto di Tomba (UD) Italy
Numero REA UD - 296214
Data di iscrizione al Registro delle
Imprese di UDINE: 01/07/2017
Numero d'iscrizione: 02895910301
Capitale sociale euro 3.000.000